Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/15212
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.otherUCH. Departamento de Ciencias Biomédicas-
dc.contributor.otherProducción Científica UCH 2023-
dc.creatorPonce Mora, Alejandro-
dc.creatorYuste Rivero, Andrea-
dc.creatorPerini Villanueva, Giuliana-
dc.creatorMiranda Sanz, María-
dc.creatorBejarano Fernández, Eloy-
dc.date.accessioned2024-01-29T15:14:43Z-
dc.date.available2024-01-29T15:14:43Z-
dc.date.issued2023-07-14-
dc.identifier.citationPonce-Mora, A., Yuste, A., Perini-Villanueva, G., Miranda, M. & Bejarano, E. (2023). Connexins biology in the pathophysiology of retinal diseases. In: Ash, J.D., Pierce, E., Anderson, R.E., Bowes Rickman, C., Hollyfield, J.G., Grimm, C. (eds). Retinal degenerative diseases XIX (pp. 229–234). Berlin (Germany): Springer Nature. Advances in experimental Medicine and Biology, vol 1415. DOI: https://doi.org/10.1007/978-3-031-27681-1_33es_ES
dc.identifier.isbn9783031276804-
dc.identifier.isbn9783031276811 (Electrónico)-
dc.identifier.urihttp://hdl.handle.net/10637/15212-
dc.descriptionEste recurso no está disponible en acceso abierto por política de la editorial.-
dc.description.abstractConnexins (Cx) are a family of transmembrane proteins that form gap junction intercellular channels that connect neighboring cells. These channels allow the passage of ions and other biomolecules smaller than 1 kDa, thereby synchronizing the cells both electrically and metabolically. Cxs are expressed in all retinal cell types and the diversity of Cx isoforms involved in the assembly of the channels provides a functional syncytium required for visual transduction. In this chapter, we summarize the status of current knowledge regarding Cx biology in retinal tissues and discuss how Cx dysfunction is associated with retinal disease pathophysiology. Although the contribution of Cx deficiency to retinal degeneration is not well understood, recent findings present Cx as a potential therapeutic target. Therefore, we will briefly discuss pharmacological approaches and gene therapies that are being explored to modulate Cx function and fight sight-threatening eye diseases.es_ES
dc.language.isoenes_ES
dc.publisherSpringer Naturees_ES
dc.relationUCH. Financiación Nacional-
dc.relationUCH. Financiación Universidad-
dc.relationEste capítulo de monografía ha sido financiado por varias becas de ámbito nacional y ámbito universitario (RYC2018-024434-I, MINECO PID2020-119466RB-I00, FUSP-PPC-19-B53C4C64).-
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.es-
dc.subjectEnfermedades_ES
dc.subjectDiseaseses_ES
dc.subjectVistaes_ES
dc.subjectEyesightes_ES
dc.subjectCélulaes_ES
dc.subjectCellses_ES
dc.subjectFisiopatologíaes_ES
dc.subjectPhysiology, Pathologicales_ES
dc.subjectFarmacologíaes_ES
dc.subjectPharmacologyes_ES
dc.titleConnexins biology in the pathophysiology of retinal diseaseses_ES
dc.typeCapítuloes_ES
dc.relation.projectIDRYC2018-024434-I-
dc.relation.projectIDPID2020-119466RB-I00-
dc.relation.projectIDFUSP-PPC-19-B53C4C64-
dc.centroUniversidad Cardenal Herrera-CEU-
Aparece en las colecciones: Dpto. Ciencias Biomédicas




Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.